21:04:58 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandSverige
ListaSmall Cap Stockholm
SektorHälsovård
IndustriVård & Omsorg
GHP Specialty Care är verksamma inom vård och omsorg. Idag bedriver bolaget specialistkliniker inom ryggkirurgi/ryggvård, specialisttandvård, fetmakirurgi och metabola sjukdomar, ortopedi samt arytmi. Verksamheten är koncentrerad till den nordiska marknaden och bolaget är verksamma inom ett flertal globala regioner. GHP Specialty Care etablerades under 2006 och har sitt huvudkontor i Göteborg.

Kalender

2021-10-22 Kvartalsrapport 2021-Q3
2021-07-13 Kvartalsrapport 2021-Q2
2021-04-30 Ordinarie utdelning GHP 0.50 SEK
2021-04-29 Årsstämma 2021
2021-04-22 Kvartalsrapport 2021-Q1
2021-02-23 Bokslutskommuniké 2020
2020-10-22 Kvartalsrapport 2020-Q3
2020-07-10 Kvartalsrapport 2020-Q2
2020-04-24 Ordinarie utdelning GHP 0.00 SEK
2020-04-23 Årsstämma 2020
2020-04-22 Kvartalsrapport 2020-Q1
2020-02-19 Bokslutskommuniké 2019
2019-10-24 Kvartalsrapport 2019-Q3
2019-07-12 Kvartalsrapport 2019-Q2
2019-04-25 Ordinarie utdelning GHP 0.30 SEK
2019-04-24 Årsstämma 2019
2019-04-23 Kvartalsrapport 2019-Q1
2019-02-20 Bokslutskommuniké 2018
2018-10-25 Kvartalsrapport 2018-Q3
2018-07-13 Kvartalsrapport 2018-Q2
2018-04-26 Ordinarie utdelning GHP 0.00 SEK
2018-04-25 Årsstämma 2018
2018-04-24 Kvartalsrapport 2018-Q1
2018-02-21 Bokslutskommuniké 2017
2017-10-26 Kvartalsrapport 2017-Q3
2017-07-18 Kvartalsrapport 2017-Q2
2017-04-27 Ordinarie utdelning GHP 0.30 SEK
2017-04-26 Årsstämma 2017
2017-04-25 Kvartalsrapport 2017-Q1
2017-02-22 Bokslutskommuniké 2016
2016-10-28 Kvartalsrapport 2016-Q3
2016-07-15 Kvartalsrapport 2016-Q2
2016-04-28 Ordinarie utdelning GHP 0.15 SEK
2016-04-27 Årsstämma 2016
2016-04-26 Kvartalsrapport 2016-Q1
2016-02-24 Bokslutskommuniké 2015
2015-10-29 Kvartalsrapport 2015-Q3
2015-07-14 Kvartalsrapport 2015-Q2
2015-04-30 Ordinarie utdelning GHP 0.13 SEK
2015-04-29 Årsstämma 2015
2015-04-28 Kvartalsrapport 2015-Q1
2015-02-19 Bokslutskommuniké 2014
2014-10-31 Analytiker möte 2014
2014-10-31 Kvartalsrapport 2014-Q3
2014-07-15 Kvartalsrapport 2014-Q2
2014-04-30 Ordinarie utdelning GHP 0.00 SEK
2014-04-29 Årsstämma 2014
2014-04-28 Kvartalsrapport 2014-Q1
2014-02-20 Bokslutskommuniké 2013
2013-10-30 Analytiker möte 2013
2013-10-30 Kvartalsrapport 2013-Q3
2013-07-15 Kvartalsrapport 2013-Q2
2013-05-03 Ordinarie utdelning GHP 0.00 SEK
2013-05-02 Årsstämma 2013
2013-04-26 Kvartalsrapport 2013-Q1
2013-03-13 15-7 2013
2013-02-26 Bokslutskommuniké 2012
2012-11-28 Extra Bolagsstämma 2012
2012-11-02 Analytiker möte 2012
2012-11-02 Kvartalsrapport 2012-Q3
2012-07-17 Kvartalsrapport 2012-Q2
2012-05-04 Ordinarie utdelning GHP 0.00 SEK
2012-05-03 Årsstämma 2012
2012-04-27 Kvartalsrapport 2012-Q1
2012-02-24 Bokslutskommuniké 2011
2011-11-01 Kvartalsrapport 2011-Q3
2011-07-19 Kvartalsrapport 2011-Q2
2011-05-05 Ordinarie utdelning GHP 0.00 SEK
2011-05-04 Årsstämma 2011
2011-04-28 Kvartalsrapport 2011-Q1
2011-02-23 Bokslutskommuniké 2010
2010-11-02 Kvartalsrapport 2010-Q3
2010-07-19 Kvartalsrapport 2010-Q2
2010-04-30 Ordinarie utdelning GHP 0.00 SEK
2010-04-29 Årsstämma 2010
2010-04-26 Kvartalsrapport 2010-Q1
2010-02-20 Bokslutskommuniké 2009
2009-11-03 Kvartalsrapport 2009-Q3
2009-07-20 Kvartalsrapport 2009-Q2
2009-04-30 Ordinarie utdelning GHP 0.00 SEK
2009-04-29 Kvartalsrapport 2009-Q1
2009-04-29 Årsstämma 1
2021-04-29 18:30:00

The Annual General Meeting of GHP Specialty Care AB held on 29 April 2021 adopted the following resolutions:

  • A dividend of SEK 0.50 per share will be paid for the financial year 2020. The record day is Monday 3 May 2021 and the dividend will be paid on Thursday 6 May 2021.
  • Decisions were made for discharge to the Board and the CEO for the 2020 fiscal year.
  • Re-election of the members of the Board Carsten Browall, Bo Wahlström, Mikael Olsson, Johan Wachtmeister, Elisabeth Hansson and Dag Andersson, and election of the new member of the Board, Ingemar Gladh, in accordance with the proposal of the nomination committee. Carsten Browall was elected as Chairman of the Board. A fee of SEK 600,000 was approved for the Chairman of the Board and SEK 250,000 for each of the other six members of the Board, that is a total of SEK 2,100,000, excluding committee work. In addition, it was decided that the Chairman of the Investment Committee and the Chairman of the Audit Committee receives SEK 50,000 each.
  • Re-election of Ernst & Young AB as auditor, in accordance with the Nomination Committee's proposal and the Audit Committee's recommendation.
  • The Board of Directors was authorized to decide for the time until the next Annual General Meeting, on one or more occasions and with or without deviation from the shareholders' preferential right, to issue new shares corresponding to a maximum of 20 percent of the total number of registered shares in the company at the time of the Annual General Meeting 2021. A new share issue with deviation from the shareholders' preferential rights may be utilized for financing acquisitions of companies or part of companies, for raising capital and to adapt the company's capital structure.
  • The Board was authorized, for the time up until the next Annual General Meeting, to decide on the acquisition of a maximum of so many own shares that the Company's holding at any given time not exceed 9.0 percent of all shares in the company.
  • It was decided to introduce the incentive program 2021/2024 by issuing 400,000 warrants to Global Health Partner Swe AB and approving the transfer of warrants to senior executives within the group at estimated market value. Each warrant entitles to subscribe for one share in the company during the period from May 10, 2024 to June 30, 2024. The subscription price for new shares and the market value of the warrants according to the Black & Scholes model is based on a subscription price upon exercise of the warrants of 130 percent of the volume-weighted average pay price for the company's share on Nasdaq Stockholm during the period from April 30, 2021 to May 15, 2021.
  • It was decided to approve the renumeration report, in accordance with the Board’s proposal.
  • The proposal for a resolution on nomination committee work for the 2022 Annual General Meeting was approved.